StemoniX wins the 2018 MinneInno InnoBlazer in the Health and Wellness category
January 25, 2018 – Since winning the Minnesota Cup’s grand prize in 2016, StemoniX has landed $2.5 million in seed funding and moved into its first headquarters and manufacturing facility in Maple Grove. The company has also cemented partnerships with Pairnomix and the U.S. Military.
StemoniX® is transforming how medicine is discovered. By using skin or blood to create functioning microHearts® and microBrains®, StemoniX is making it possible to test medication on humans without that medication ever entering their bodies. This method of drug testing will speed up the search for new cures and enable the ability to test drug effectiveness on an individual person, so medicine works correctly the first time. For more information visit www.stemonix.com.